Literature DB >> 8288945

Membrane signaling by complement C5b-9, the membrane attack complex.

A Nicholson-Weller1, J A Halperin.   

Abstract

The terminal complement complexes C5b-7, C5b-8 and C5b-9 are able to generate nonlethal cell signals. One universal consequence of a cell being targeted by C5b-8 or C5b-9 is an influx of Ca2+. In addition, other second messengers, including cAMP, inositol phosphate intermediates and arachidonate metabolites, are generated by the terminal complement complexes in specific cell types. In vivo, terminal complement complexes have been found in a wide variety of inflammatory processes in humans and in experimental animal models. Some of these models of inflammation putatively induced by terminal complement complexes have been tested in complement-deficient animals, and indeed no inflammation results, which supports the critical role of the terminal complement complexes in the pathogenesis of the lesion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288945     DOI: 10.1007/BF02918256

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  78 in total

1.  Membrane vesiculation protects erythrocytes from destruction by complement.

Authors:  K Iida; M B Whitlow; V Nussenzweig
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

2.  Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination.

Authors:  D F Carney; T J Lang; M L Shin
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

3.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity.

Authors:  P J Sims; E M Faioni; T Wiedmer; S J Shattil
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

4.  Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  M H Holguin; L R Fredrick; N J Bernshaw; L A Wilcox; C J Parker
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex.

Authors:  T E Mollnes; T Lea; O J Mellbye; J Pahle; O Grand; M Harboe
Journal:  Arthritis Rheum       Date:  1986-06

6.  Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.

Authors:  D F Carney; C L Koski; M L Shin
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

7.  Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis.

Authors:  G C Groggel; D J Salant; C Darby; H G Rennke; W G Couser
Journal:  Kidney Int       Date:  1985-04       Impact factor: 10.612

8.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.

Authors:  H F Weisman; T Bartow; M K Leppo; H C Marsh; G R Carson; M F Concino; M P Boyle; K H Roux; M L Weisfeldt; D T Fearon
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

9.  Elimination of complement channels from the plasma membranes of U937, a nucleated mammalian cell line: temperature dependence of the elimination rate.

Authors:  L E Ramm; M B Whitlow; C L Koski; M L Shin; M M Mayer
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

10.  Thromboxane B2 synthesis in human platelets induced by the late complement components C5b-9.

Authors:  M Betz; M Seitz; G M Hänsch
Journal:  Int Arch Allergy Appl Immunol       Date:  1987
View more
  42 in total

Review 1.  Renal ischemia--reperfusion injury: an inescapable event affecting kidney transplantation outcome.

Authors:  R Böhmová; O Viklický
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

2.  CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytes.

Authors:  C H Nielsen; H V Marquart; W M Prodinger; R G Leslie
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

3.  Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement.

Authors:  Mausumi Bandyopadhyay; Bärbel Rohrer
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

4.  Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.

Authors:  R J Quigg; C He; B K Hack; J J Alexander; B P Morgan
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 5.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 6.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

Review 7.  The role of complement in inflammatory diseases from behind the scenes into the spotlight.

Authors:  Maciej M Markiewski; John D Lambris
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

8.  The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury.

Authors:  Jinyan Zhang; Weiguo Hu; Wei Xing; Tao You; Junming Xu; Xuebin Qin; Zhihai Peng
Journal:  Am J Pathol       Date:  2011-10-19       Impact factor: 4.307

9.  Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells.

Authors:  Michael T Eadon; Alexander Jacob; Patrick N Cunningham; Richard J Quigg; Joe G N Garcia; Jessy J Alexander
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

10.  Trimellitic anhydride-induced allergic response in the lung: role of the complement system in cellular changes.

Authors:  D G Fraser; J F Regal; M L Arndt
Journal:  J Pharmacol Exp Ther       Date:  1995-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.